Skip to main navigation Skip to search Skip to main content

Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery

  • Gemma Navarro
  • , Gelja Maiwald
  • , Rudolf Haase
  • , Andrey L. Rogach
  • , Ernst Wagner
  • , Conchita Tros de Ilarduya
  • , Manfred Ogris

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)99-105
Number of pages7
JournalJournal of Controlled Release
Volume146
Issue number1
DOIs
Publication statusPublished - 17 Aug 2010
Externally publishedYes

Funding

This work was supported by FUN (University of Navarra Foundation), Government of Navarra (Department of Education) and Bancaja Foundation, the EC funded project GIANT, DFG SFB486 and SPP1230, and the DFG Excellence Cluster "Nanosystems Initiative Munich" (NIM). Melinda Kiss is gratefully acknowledged for technical assistance.

Austrian Fields of Science 2012

  • 301207 Pharmaceutical chemistry

Keywords

  • PAMAM dendrimer
  • Tumor targeting
  • CpG free plasmid
  • GENE DELIVERY
  • IN-VIVO
  • LINEAR POLYETHYLENIMINE
  • DNA COMPLEXES
  • VITRO
  • POLYPLEXES
  • VECTOR
  • LUNG
  • TRANSFECTION
  • DYNAMICS

Fingerprint

Dive into the research topics of 'Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery'. Together they form a unique fingerprint.

Cite this